PLIANT THERAPEUTICS INC's ticker is PLRX and the CUSIP is 729139105. A total of 90 filers reported holding PLIANT THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 2.35 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $106,498 | +114.0% | 6,142 | +123.7% | 0.00% | – |
| Q2 2023 | $49,754 | +32.2% | 2,746 | +94.1% | 0.00% | – |
| Q1 2023 | $37,635 | +246.4% | 1,415 | +163.5% | 0.00% | – |
| Q4 2022 | $10,866 | +262.2% | 537 | +300.7% | 0.00% | – |
| Q3 2022 | $3,000 | – | 134 | +294.1% | 0.00% | – |
| Q2 2022 | $0 | – | 34 | 0.0% | 0.00% | – |
| Q1 2022 | $0 | – | 34 | +100.0% | 0.00% | – |
| Q4 2021 | $0 | -100.0% | 17 | -88.7% | 0.00% | – |
| Q2 2021 | $4,000 | -66.7% | 150 | -50.0% | 0.00% | – |
| Q1 2021 | $12,000 | -45.5% | 300 | -68.4% | 0.00% | – |
| Q4 2020 | $22,000 | -18.5% | 950 | -19.1% | 0.00% | – |
| Q3 2020 | $27,000 | -53.4% | 1,175 | -34.7% | 0.00% | – |
| Q2 2020 | $58,000 | – | 1,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 5,839,160 | $98,565,000 | 18.71% |
| CHI Advisors LLC | 2,484,724 | $41,942,000 | 12.24% |
| TRV GP IV, LLC | 2,132,867 | $36,003,000 | 8.17% |
| Bond & Devick Financial Network, Inc. | 120,160 | $2,028,000 | 1.68% |
| Fernwood Investment Management, LLC | 166,447 | $2,810,000 | 0.96% |
| Redmile Group, LLC | 3,083,501 | $52,049,000 | 0.91% |
| HARVARD MANAGEMENT CO INC | 562,379 | $9,493,000 | 0.56% |
| Grace Capital | 48,058 | $808,000 | 0.50% |
| Eventide Asset Management | 2,183,238 | $36,853,000 | 0.49% |
| Cormorant Asset Management, LP | 482,413 | $8,143,000 | 0.33% |